Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12*
暂无分享,去创建一个
Patrick Gizzi | Jacques Haiech | Marc Parmentier | Esther Kellenberger | Marcel Hibert | E. Kellenberger | M. Parmentier | Muriel Hachet-Haas | J. Galzi | F. Baleux | N. Frossard | K. Chow | J. Haiech | F. Pons | D. Bonnet | F. Arenzana‐Seisdedos | K. Balabanian | M. Hibert | Dominique Bonnet | Fernando Arenzana-Seisdedos | S. Lecat | Françoise Baleux | Sandra Lecat | C. Franchet | Karl Balabanian | Bernard Lagane | Rania Dagher | Bruno Didier | Nelly Frossard | R. Dagher | Muriel Hachet-Haas | François Rohmer | Françoise Pons | Christel Franchet | Ken Y. C. Chow | Jean-luc Galzi | B. Lagane | P. Gizzi | F. Rohmer | B. Didier | Muriel Hachet‐Haas
[1] B. Dewald,et al. N-terminal Peptides of Stromal Cell-derived Factor-1 with CXC Chemokine Receptor 4 Agonist and Antagonist Activities* , 1998, The Journal of Biological Chemistry.
[2] T. Springer,et al. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] N Nandhagopal,et al. Crystal structure of recombinant native SDF-1alpha with additional mutagenesis studies: an attempt at a more comprehensive interpretation of accumulated structure-activity relationship data. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[4] N. Yoshida,et al. A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection , 1997, The Journal of experimental medicine.
[5] R. Gorlin,et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease , 2003, Nature Genetics.
[6] A. Otaka,et al. Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection. , 1998, Bioorganic & medicinal chemistry.
[7] J. Broach,et al. A Point Mutation That Confers Constitutive Activity to CXCR4 Reveals That T140 Is an Inverse Agonist and That AMD3100 and ALX40-4C Are Weak Partial Agonists* , 2002, The Journal of Biological Chemistry.
[8] Masahiko Kuroda,et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.
[9] E. Fernandez,et al. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1α, a potent ligand for the HIV-1 “fusin” coreceptor , 1998 .
[10] Ji Ming Wang,et al. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. , 2000, Biochemical and biophysical research communications.
[11] Mette M. Rosenkilde,et al. Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor , 2004, Journal of Biological Chemistry.
[12] R. Bronson,et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[14] R. Steinman,et al. Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors , 1996, The Journal of experimental medicine.
[15] Kevin Wei,et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.
[16] E. Schijlen,et al. Modification of flavonoid biosynthesis in crop plants. , 2004, Phytochemistry.
[17] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[18] Michelle R. Arkin,et al. Binding of small molecules to an adaptive protein–protein interface , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Galzi,et al. Rapid Internalization and Recycling of the Human Neuropeptide Y Y1 Receptor* , 2002, The Journal of Biological Chemistry.
[20] J. Galzi,et al. Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties , 2003, Journal of neurochemistry.
[21] B. Volkman,et al. The monomer–dimer equilibrium of stromal cell‐derived factor‐1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin , 2005, Protein science : a publication of the Protein Society.
[22] A. Koniski,et al. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. , 1999, Developmental biology.
[23] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[24] F. Balkwill. The significance of cancer cell expression of the chemokine receptor CXCR4. , 2004, Seminars in cancer biology.
[25] Alain Dupuy,et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. , 2005, Blood.
[26] M. Delepierre,et al. Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine* , 1999, The Journal of Biological Chemistry.
[27] M. Thelen,et al. The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes* , 2005, Journal of Biological Chemistry.
[28] Fred E. Cohen,et al. In vitro antimalarial activity of chalcones and their derivatives. , 1995, Journal of medicinal chemistry.
[29] Dominique Schols,et al. AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. , 2002, The American journal of pathology.
[30] E. De Clercq,et al. Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. , 1997, Antiviral research.
[31] M. Baba,et al. T134, a Small-Molecule CXCR4 Inhibitor, Has No Cross-Drug Resistance with AMD3100, a CXCR4 Antagonist with a Different Structure , 1999, Journal of Virology.
[32] V. Anuradha,et al. Isolation and synthesis of analgesic and anti-inflammatory compounds from Ochna squarrosa L. , 2006, Bioorganic & medicinal chemistry.
[33] Didier Rognan,et al. sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank , 2006, J. Chem. Inf. Model..
[34] K. Ohta,et al. Chemokine receptor expression profile of eosinophils at inflamed tissue sites: Decreased CCR3 and increased CXCR4 expression by lung eosinophils. , 2001, The Journal of allergy and clinical immunology.
[35] Robin Taylor,et al. Life-science applications of the Cambridge Structural Database. , 2002, Acta crystallographica. Section D, Biological crystallography.
[36] W. Gong,et al. The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. , 2000, Immunopharmacology.
[37] Z. Darżynkiewicz,et al. Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines , 2001, Cell proliferation.
[38] Kouji Matsushima,et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.
[39] Y. Percherancier,et al. Palmitoylation-dependent Control of Degradation, Life Span, and Membrane Expression of the CCR5 Receptor* , 2001, The Journal of Biological Chemistry.
[40] J. Galzi,et al. Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1α Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.
[41] Takashi Suzuki,et al. Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. , 2006, Journal of natural products.
[42] G. Clore,et al. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha. , 2005, Journal of molecular biology.
[43] S. Shorte,et al. CXCR4-Tropic HIV-1 Envelope Glycoprotein Functions as a Viral Chemokine in Unstimulated Primary CD4+ T Lymphocytes1 , 2004, The Journal of Immunology.
[44] A. Úbeda,et al. Novel anti‐inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase‐2 in mouse peritoneal macrophages , 1999, FEBS letters.
[45] Didier Rognan,et al. Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..
[46] M. Fukushima,et al. Baicalin, an inhibitor of HIV-1 production in vitro. , 1998, Antiviral research.
[47] N. Frossard,et al. Exposure to Endotoxins during Sensitization Prevents Further Endotoxin-Induced Exacerbation of Airway Inflammation in a Mouse Model of Allergic Asthma , 2005, International Archives of Allergy and Immunology.
[48] A. Otaka,et al. Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes. , 2000, Bioorganic & medicinal chemistry letters.
[49] J. Galzi,et al. Subcellular Compartmentalization of Activation and Desensitization of Responses Mediated by NK2 Neurokinin Receptors* , 1999, The Journal of Biological Chemistry.
[50] A. Peled,et al. Critical Involvement of the Chemotactic Axis CXCR4/Stromal Cell-Derived Factor-1α in the Inflammatory Component of Allergic Airway Disease , 2000, The Journal of Immunology.
[51] M. Alcaraz,et al. 1-(2,3,4-trimethoxyphenyl)-3-(3-(2-chloroquinolinyl))-2-propen-1-one, a chalcone derivative with analgesic, anti-inflammatory and immunomodulatory properties , 2003, Inflammation Research.
[52] Li-Ming Zhou,et al. Chalcones and flavonoids as anti-tuberculosis agents. , 2002, Bioorganic & medicinal chemistry.
[53] M. Alcaraz,et al. A new chloroquinolinyl chalcone derivative as inhibitor of inflammatory and immune response in mice and rats , 2003, The Journal of pharmacy and pharmacology.
[54] E. Kellenberger,et al. Redesign of Schistosoma mansoni NAD+ catabolizing enzyme: active site H103W mutation restores ADP-ribosyl cyclase activity. , 2006, Biochemistry.
[55] W. Rocque,et al. Solution studies of recombinant human stromal-cell-derived factor-1. , 2001, Protein expression and purification.
[56] Elias Lolis,et al. Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.
[57] S. Edelstein,et al. The Neurokinin A Receptor Activates Calcium and cAMP Responses through Distinct Conformational States* , 2001, The Journal of Biological Chemistry.